Related Experiment Video
Updated: Jul 2, 2025
04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
930
Elevated INHBA Promotes Tumor Progression of Cervical Cancer
Zhenghong Wu1, Jina Chen1, Lina Yang1
1Department of Gynecology and Obstetrics, Shanghai Fifth People's Hospital, Fudan University, Shanghai, P.R. China.
Technology in Cancer Research & Treatment
|February 29, 2024
Summary
Inhibin subunit beta A (INHBA) is upregulated in cervical cancer, promoting tumor growth and metastasis. Targeting INHBA may offer a new therapeutic strategy for cervical cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cervical cancer (CCa) remains a significant global health challenge.
- Understanding the molecular drivers of CCa progression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of inhibin subunit beta A (INHBA) in cervical cancer progression.
- To evaluate INHBA as a potential therapeutic target for CCa.
- To assess the correlation between INHBA expression and patient survival.
Main Methods:
- Analysis of INHBA expression in CCa tissues.
- Correlation of INHBA levels with patient survival data.
- In vitro studies on CCa cell proliferation, cell cycle, migration, and invasion (EMT).
- In vivo experiments assessing tumor growth and lung metastasis.
Main Results:
- INHBA expression is significantly upregulated in CCa.
- High INHBA expression correlates with poor patient survival.
- INHBA promotes CCa cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
- INHBA enhances tumor growth and lung metastasis in vivo.
Conclusions:
- INHBA is a key driver of cervical cancer progression.
- Targeting INHBA presents a promising therapeutic strategy for CCa.
- This study provides insights into CCa's molecular mechanisms and potential treatments.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K